Evidence map›Paper›PMID 35590802›Full record

ArticleSensors (Basel, Switzerland)2022

LightEyes: A Lightweight Fundus Segmentation Network for Mobile Edge Computing.

Song Guo

Abstract read
In one paragraph

Article in Sensors (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Song GuoSchool of Information and Control Engineering, Xi'an University of Architecture and Technology, Xi'an 710055, China.ORCID 0000-0001-6841-753X

Funding

Xi'an University of Architecture and Technology 1960320048
6 · The paper itself

Abstract

Fundus is the only structure that can be observed without trauma to the human body. By analyzing color fundus images, the diagnosis basis for various diseases can be obtained. Recently, fundus image segmentation has witnessed vast progress with the development of deep learning. However, the improvement of segmentation accuracy comes with the complexity of deep models. As a result, these models show low inference speeds and high memory usages when deploying to mobile edges. To promote the deployment of deep fundus segmentation models to mobile devices, we aim to design a lightweight fundus segmentation network. Our observation comes from the fact that high-resolution representations could boost the segmentation of tiny fundus structures, and the classification of small fundus structures depends more on local features. To this end, we propose a lightweight segmentation model called LightEyes. We first design a high-resolution backbone network to learn high-resolution representations, so that the spatial relationship between feature maps can be always retained. Meanwhile, considering high-resolution features means high memory usage; for each layer, we use at most 16 convolutional filters to reduce memory usage and decrease training difficulty. LightEyes has been verified on three kinds of fundus segmentation tasks, including the hard exudate, the microaneurysm, and the vessel, on five publicly available datasets. Experimental results show that LightEyes achieves highly competitive segmentation accuracy and segmentation speed compared with state-of-the-art fundus segmentation models, while running at 1.6 images/s Cambricon-1A speed and 51.3 images/s GPU speed with only 36k parameters.

Indexed as

Neural Networks, ComputerRetinal VesselsExudates and TransudatesFundus OculiHumansImage Processing, Computer-Assistedfast semantic segmentationfundus imagelightweight networkmobile edge computing

Identifiers

PMID35590802
PMCPMC9104959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.